FindTrial
Sign In

A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province

A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031504
Enrollment
Unknown
Registered
2020-04-03
Start date
2019-12-01
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatic disease

Interventions

Rheumatic disease with COVID-19:N/A
Rheumatic disease without COVID-19:N/A

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Rheumatic disease; 2. Residents in Hubei province; 3. > 18 years old.

Exclusion criteria

Exclusion criteria: 1. unclear diagnosis; 2. participants are not able to understand or cooperate; 3. malignancy; 4. pregnancy or abortion; 5. breast-feeding.

Design outcomes

Primary

MeasureTime frame
Infection;—

Countries

China

Contacts

Public ContactLingli Dong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

393176736@qq.com+86 02783665518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026